6505--VA Loma Linda Radiopharmaceuticals

36C26224Q1356

0001

The amendment 0001 against the solicitation 36C26224Q1356

Is issued to post vendor s RFIs and VA s response. Refer to page 4 and 5.

Shall extend the response due date from 7/22/2024 10am Pacific Local Time through 7/30/2024 10am Pacific Local Time.

All other terms and conditions remain unchanged.

Q&A

There appear to be duplicates entry requests as all are WBC tagging. Are we allowed to amend this, or is the duplicate to be bid upon as listed?

Tc-99 Macro Aggregated Albumin UD

100

Tc99m MAA 1-6 mCi dose

100

Tc-99m Non =-HEU Macro Aggregated Albumin

100

VA s response: They are not duplicates. These are not being used for WBC Imaging. Tc99m MAA is what VA Loma Linda uses for Lung imaging. VA Loma Linda requires both the NON-HEU and 1-6 mCi dose.

In this section all items have the non-HEU designation, but this is the only type of products we carry so this would also prove to be a duplicate and skew our bid total. Are we able to proceed with just the non-HEU products?

Tc-99m non- HEU Examatazime UD

5

Tc-99m Non-HEU Filtered Sulfer Colloid U

135

Tc-99m Non =-HEU Macro Aggregated Albumin

100

Tc-99m Non- HEU Mebrofenin UD

150

Tc-99m Non_HEU Medronate UD

600

Tc-99m Non -HEU Mertiatide UD

65

Tc-99m Non-HEU NaTc04 MD

30

Tc-99m Non-HEU NaTc04 UD mCi

25

Tc-99m Non-HEU Pentetate UD

100

Tc-99m Non-HEU Pyrophosphate UD

15

Tc-99m Non-HEU Sestamibi UD

60

Tc-99m Non-HEU Sulfer Colloid UD

135

Tc-99m Non-HEU Tetrofsmin UD

2,500

Tc-99m Non- HEU Autologous WBC Suspension

25

VA s Response: VA Loma Linda requires NON-HEU products for these isotopes.

These items are also duplicated, and we would only be able to service you properly if we know how many Curies/how much activity is needed for your linearity. Can you speak to this?

Tc- 99m NaTc04 MD

30

Tc-99m Non-HEU NaTc04 MD

30

VA s Response: These are not duplicated; these two are different. One is NON-HEU and one is not. VA Loma Linda requires both.

The item below is a sole source item that we do not have the rights to. Is it possible to have this product removed, or is it permissible to substitute with sulfur colloid as has been done at other VA facilities?

Lymphoseek Study Dose

86

VA s Response: VA Loma Linda will accept substitutes of Lymphoseek; however, it must have an equal to characteristics to Lymphoseek. An equivalent radiopharmaceutical to Lymphoseek must have following salient characteristics:

Must be able to be injected the day before surgery or on the day of the surgery; to provide optimal scheduling for patients to avoid delays in operating rooms.

Must have a same or better detection of sentinel node.

Must have a same or better detection rate.

Must be an equal to radiopharmaceutical that can be used to exam to locate lymph nodes for patients who have Melanoma.

The FAR Clause 52.211-6 Brand Name or Equal applies to this acquisition. Any items quoted as equal not confirming to the requirements of clause 52.211-6 will be considered non- responsive and not considered for award.

This is a combined synopsis/solicitation is full and open/unrestricted for commercial supplies prepared in accordance with the format in Subpart 12.6, as supplemented with the additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This is a request for quotes under solicitation number: 36C26224Q1356

The Department of Veterans Affairs Loma Linda Healthcare system intends to enter into a single award Indefinite-delivery Indefinite-quantity (IDIQ) contract for base plus option four years for following radiopharmaceuticals. The Contractor shall furnish all supplies/services at The VA Loma Linda Healthcare System Nuclear Medicine/Imaging Service 11201 Benton St, Loma Linda, CA 92357 in accordance with section B.2 STATEMENT OF WORK under this solicitation. Shipping cost must be included in the total cost.

No remanufactures or gray market items will be acceptable. Vendor shall be an Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor or authorized reseller verified by an authorization letter or other documents from the OEM.

Period of Performance

Base: 10/1/2024 9/30/2025

Option year 1 (OY1): 10/1/2025 9/30/2026

Option year 2 (OY2): 10/1/2026 9/30/2027

Option year 3 (OY3): 10/1/2027 9/30/2028

Option year 4 (OY4): 10/1/2028 9/30/2029

Requesting Radiopharmaceuticals

Base Year Estimated Quantities

OY1 Estimated Quantities

OY2 Estimated Quantities

OY3 Estimated Quantities

OY4 Estimated Quantities

18-FDG 12 mCi per dose

240

240

240

240

240

F18 NAF 10 mCi

240

240

240

240

240

F-18 FDG US (30mCi max)- Linearity- Source

4

4

4

4

4

F-18 FDG Dispensing Fee

240

240

240

240

240

Sodium Iodine I-123 200 uci per dose

35

35

35

35

35

Sodium Iodide I-131 First 6 mCi (Diagnostic)

10

10

10

10

10

Sodium Iodide I-131 Therapy Caps each additional mCi

30

30

30

30

30

In-111 Pentetreotide UD

25

25

25

25

25

Tc99m-Pyrophsophate

50

50

50

50

50

Sincalide Vile

80

80

80

80

80

Tc99m SC Filtered 1 mCi dose

17

17

17

17

17

Tc-99 Macro Aggregated Albumin UD

100

100

100

100

100

Tc99m MAA 1-6 mCi dose

100

100

100

100

100

Tc-99m Mebrofenin UD

100

100

100

100

100

Tc-99m Medronate UD

150

150

150

150

150

Tc-99m Meritatide UD

600

600

600

600

600

Tc- 99m NaTc04 MD

30

30

30

30

30

Tc-99m NaTc04 UD mCi

25

25

25

25

25

Tc-99 Pentetate UD

100

100

100

100

100

Tc-Sestamibi 30 mCi dose

15

15

15

15

15

Tc-Sestamibi 10 mCi dose

15

15

15

15

15

Tc99m Sulfur Colloid 1-7 mCi dose

135

135

135

135

135

Tc-99m Tetrofosmin UD

2400

2400

2400

2400

2400

Tc-99m exematzine WBC's

40

40

40

40

40

Tc-99m non- HEU Examatazime UD

5

5

5

5

5

Tc-99m Non-HEU Filtered Sulfer Colloid U

135

135

135

135

135

Tc-99m Non =-HEU Macro Aggregated Albumin

100

100

100

100

100

Tc-99m Non- HEU Mebrofenin UD

150

150

150

150

150

Tc-99m Non_HEU Medronate UD

600

600

600

600

600

Tc-99m Non -HEU Mertiatide UD

65

65

65

65

65

Tc-99m Non-HEU NaTc04 MD

30

30

30

30

30

Tc-99m Non-HEU NaTc04 UD mCi

25

25

25

25

25

Tc-99m Non-HEU Pentetate UD

100

100

100

100

100

Tc-99m Non-HEU Pyrophosphate UD

15

15

15

15

15

Tc-99m Non-HEU Sestamnib UD

60

60

60

60

60

Tc-99m Non-HEU Sulfer Colloid UD

135

135

135

135

135

Tc-99m Non-HEU Tetrofsmin UD

2,500

2,500

2,500

2,500

2,500

Tc-99m Non- HEU Autologous WBC Suspension

25

25

25

25

25

Nephroscan

10

10

10

10

10

Tc-99m Non HEU Mertiatide

50

50

50

50

50

Lymphoseek Study Dose

86

86

86

86

86

Stat

300

300

300

300

300

Balloons for H Pylori breath test

4 sets

4 sets

4 sets

4 sets

4 sets

Halyard PY Test Breath Collection fluid

4

4

4

4

4

Liquid Scintillation

4 sets

4 sets

4 sets

4 sets

4 sets

C-14 Urea Capsule

150

150

150

150

150

F-18 Sodium Flouride

10

10

10

10

10

Gallium 67 5 mci

4

4

4

4

4

Thallium-201 1 mCi

10

10

10

10

10

The quantities cited above chart are estimated quantities for base and all option periods; quantities are not a contractual statement of precise quantities that the Government will order. The quantities given are estimated only, and no guarantee of their accuracy is either given or implied. The Government will only pay for quantities that are actually ordered and for which the services are fulfilled.

Pricing shall be a firm fixed-price.

Minimum order is $30,000.00 and maximum order will be no more than $5,000,000.00 on delivery orders.

The solicitation will be in accordance with FAR Part 12, Part 13, Subpart 16.5, and Part 19, Acquisition of Commercial Items, Simplified Acquisition Procedures, Indefinite-Delivery Contracts, Small Business Programs, and Veteran Affairs Acquisition Regulations as supplemented with additional information in this notice. The North American Industrial Classification System (NAICS) code for this requirement is 325412, Size Standard 1,300 Employees. The Contractor shall adhere to all federal and state laws and regulations in effect during the term of this contract. The Government intends to award a firm-fixed-price contract. The Contract begins on the date of award.

Key solicitation milestones are: Submit any questions regarding this procurement via email to Hestia.Sim@va.gov no later than 10am Pacific Local Time Wednesday, July 17, 2024. No questions will be answered after this date/time unless determined to be in the best interest of the Government as determined by the Contracting Officer. Telephonic questions will not be accepted or returned. RFI responses will be responded to as necessary in amendment format which will be posted to contract opportunities at http://SAM.gov.

Due to time constraints, responses to the solicitation shall be due on Monday, July 22, 2024 at 10:00 Pacific Time. Offerors are advised that it is your responsibility to review and monitor the website frequently to ensure you have the most up to date information, including amendments. Correspondence or questions may be directed to Hestia Sim, Contracting Specialist at Hestia.Sim@va.gov with " 36C26224Q1356, VA Loma Linda Radiopharmaceuticals in the subject line within 48 hours of release of this notice. Telephone inquiries will not be honored. Inquiries after the allotted period may not be responded to due to the time constraints of the procurement. All offerors must be registered in www.sam.gov to do business with the Government. Ensure your registration is correct, current and has not expired.